NTI 4.27% 6.1¢ neurotech international limited

Ann: Clinical Trial Preliminary Outcomes, page-180

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 118 Posts.
    Great and all, but still a long way to go.

    Until Neurotech starts pulling in that revenue for those "units" of contracts, this will still keep churning though the current cash for the time being, so the market will price this stock accordingly.

    I can see this jumped quickly, but if there is no constant news such like the last year but I could see this further rescind back to 20 cents in the short term (December) before the next major announcement and any announcements where steady sales start coming into fruition.

    Pretty frustrating stock as has lots of potential, but only in the long term. So if you have a 5 year plan then this could be a good stock (pending results of course), but buying now would still be a little risky, given the day traders are back. I would look to pick up parcels again sub 20 cents.

    While for the long term holders over the last year, I hope i'm proved wrong as there have been a lot of buyers in the 30-40 range and then topping up mid 20's to average down, but I feel this could slowly rescind, given past management announcements, cash flow churn, and day traders jumping back into the stock for the moment.
 
watchlist Created with Sketch. Add NTI (ASX) to my watchlist
(20min delay)
Last
6.1¢
Change
0.003(4.27%)
Mkt cap ! $63.11M
Open High Low Value Volume
5.8¢ 6.1¢ 5.8¢ $44.24K 747.7K

Buyers (Bids)

No. Vol. Price($)
1 36718 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.1¢ 234980 1
View Market Depth
Last trade - 15.31pm 19/11/2024 (20 minute delay) ?
NTI (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.